🖼️00AstraZeneca stock falls after FDA panel votes against new cancer drugCNBC·Elsa Ohlen·about 1 month ago#m9zsC8fw#astrazenecaplc#ftse100#pharmaceuticals#biotechandpharmaceuticals#drug#astrazeneca+5 more🧰Tag tools✨Add tagThe advisory panel wasn't convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.15s0Read later0Read More
📰00Astrazeneca tops expectations in the first quarter on strong cancer drug salesReddit r/neutralnews·u/NeutralverseBot·about 1 month ago#8UfwG45s#astrazeneca#tops#expectations#first#quarter#photo+2 more🧰Tag tools✨Add tagFrom Reddit - r/neutralnews: Astrazeneca tops expectations in the first quarter on strong cancer drug sales15s0Read later0Read More
🖼️00AstraZeneca to invest £300m in Britain after UK-US pharma dealThe Independent·The Independent·about 1 month ago#tvZDpheG#e4745c81352fee10#e04aa1c3fe49c356#million#astrazeneca#cambridge#giant+3 more🧰Tag tools✨Add tagFrom Independent RSS Feed: Pharmaceutical giant to invest £300m in Britain after UK-US deal15s0Read later0Read More
🖼️00AstraZeneca to inject £300 million into UK as Starmer hails ‘significant’ investmentThe Independent·Will Meakin-Durrant·about 1 month ago#zB80tjTa#comments#astrazeneca#million#cambridge#investment#year+2 more🧰Tag tools✨Add tagAstraZeneca chief executive Pascal Soriot has thanked the Government ‘for their efforts to improve access for patients’15s0Read later0Read More
🖼️00AstraZeneca makes surprise U-turn with £300m pharma investment in UKthe Guardian·https://www.theguardian.com/profile/juliakollewe·about 1 month ago#qmxA4w0a#navigation#img#maincontent#astrazeneca#drug#cambridge+3 more🧰Tag tools✨Add tagDrugmaker had stalled large-scale projects in England but has now pledged investment at two sites, announced by Keir Starmer15s0Read later0Read More
📰00UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policiesCNBC·Elsa Ohlen·about 1 month ago#lerxxyTm#gskplc#astrazenecaplc#rocheholdingag#stoxx600#astrazeneca#billion+5 more🧰Tag tools✨Add tagAstraZeneca and GSK, the U.K.'s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.15s0Read later0Read More
